Professional Documents
Culture Documents
MIR Cardiología
• Epidemiología
• Cuidados extrahospitalarios
• Terapia de reperfusión
• MINOCA
• Gaps en la evidencia
Hartley A, Marshall DC, Salciccioli JD, Sikkel MB, Maruthappu M, Shalhoub J. Trends in Mortality From Ischemic Heart Disease and Cerebrovascular Disease in Europe.
Circulation. 2016;133(20):1916 LP - 1926.
2.- DIAGNÓSTICO Y CUIDADOS
EXTRAHOSPITALARIOS
• El alivio del dolor con NTG no tiene utilidad como
maniobra diagnóstica (puede conducir a equivocaciones)
Dhruva VN,
Henrikson CA,Abdelhadi
Howell EE,SI, Anis
Bush A,Miles
DE, Gluckman W, Hom
JS, Meininger D,Friedlander
GR, Dougan W, T, Kaluski E, Pain
et al. Chest Haider B, Klapholz
Relief M. ST-Segment
by Nitroglycerin Analysis
Does Not Predict ActiveUsing
Coronary
Artery Disease.
Wireless Ann Intern
Technology in Med.
Acute2003;139:979–986.
Myocardial Infarction (STAT-MI) trial. J Am Coll Cardiol 2007;50(6):509–513.
2.- DIAGNÓSTICO Y CUIDADOS
EXTRAHOSPITALARIOS
• El alivio del dolor con NTG no tiene utilidad como maniobra
diagnóstica (puede conducir a equivocaciones)
• ST >= 2 mm
• Mujeres
• IAM Inferior
Infarto
Ictus
Menores eventos
Engstrom T et al. Complete revascularisation versus
treatment of the culprit lesion only in patients with ST- relacionados con Smits PC et al. Compare-Acute Investigators. Fractional
segment elevation myocardial infarction and multivessel flow reserve-guided multivessel angioplasty in myocardial
disease (DANAMI-3-PRIMULTI): an open-label, randomised nuevas infarction. N Engl J Med 2017;376(13):1234–1244.
controlled trial. Lancet 2015;386(9994):665–671.
revascularizaciones
Tratamiento
médico
periprocedimiento
Mortalidad
Silvain J et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ
2012;344:e553.
Leonardi S et al. Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised
controlled trial. BMJ 2016;354:i4935.
Fibrinolisis
4.- MANEJO DURANTE LA
HOSPITALIZACIÓN
Melberg T et al. Safety and health status following early Azzalini L et al. Feasibility and safety of an early discharge
discharge in patients with acute myocardial infarction treated strategy after low-risk acute myocardial infarction treated
with primary PCI: a randomized trial. Eur J Prev Cardiol with primary percutaneous coronary intervention:
2015;22(11):1427–1434. the EDAMI pilot trial. Cardiology 2015;130(2):120–129.
Pacientes en tratamiento
anticoagulante
Marco Valgimigli et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual
antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart
J. 2017 Aug 26.
DAPT+ACO
DAPT+ Rivaroxaban
2,5 c/12
Clopidogrel-
Rivaroxaban 15
Gibson CM et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 2016;375(25):2423–2434.
Pacientes con enfermedad
renal crónica
Pacientes no
reperfundidos
Evaluación del riesgo
Edad
Taquicardia
hTA
Killip >1
IAM anterior
IM previo
FRA
Enfermedad arterial periférica
GRACE
FEVi
Severidad de la enfermedad coronaria e
isquemia residual
Marcadores metabólicos (LDLc, HDL, TG)
Estudio de imagen
Eitel I, et al. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 2014;64(12):1217–1226.
5.- TRATAMIENTO A LARGO
PLAZO
• CONDUCTA
Castellano, J.M. et al. J Am Coll Cardiol. 2014; 64(20):2071–82.
Tratamiento médico
Bonaca MP et al. PEGASUS-TIMI 54 Steering Committee and Investigators. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med
2015;372(19):1791–1800.
Metocard-CNIC
Early-BAMI
IMPROVE-IT
FOURIER
6.- COMPLICACIONES DEL
IAMCEST
FA permanente
Todos (FA)
FA paroxística
Ritmo sinusal
Batra G et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart 2016;102(12):926–933.
7.- INFARTO DE MIOCARDIO SIN
ESTENOSIS CORONARIA SIGNIFICATIVA
8.- LAGUNAS DE LA
EVIDENCIA CIENTÍFICA
• Reducción de la lesión por isquemia-reperfusión